These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 10942386)

  • 21. Induction of the angiogenic modulator fibroblast growth factor-binding protein by epidermal growth factor is mediated through both MEK/ERK and p38 signal transduction pathways.
    Harris VK; Coticchia CM; Kagan BL; Ahmad S; Wellstein A; Riegel AT
    J Biol Chem; 2000 Apr; 275(15):10802-11. PubMed ID: 10753873
    [TBL] [Abstract][Full Text] [Related]  

  • 22. JNK mediates TGF-beta1-induced epithelial mesenchymal transdifferentiation of mouse transformed keratinocytes.
    Santibañez JF
    FEBS Lett; 2006 Oct; 580(22):5385-91. PubMed ID: 16989819
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cellular response to alkylating agent MNNG is impaired in STAT1-deficients cells.
    Ah-Koon L; Lesage D; Lemadre E; Souissi I; Fagard R; Varin-Blank N; Fabre EE; Schischmanoff O
    J Cell Mol Med; 2016 Oct; 20(10):1956-65. PubMed ID: 27464833
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Involvement of ERK1/2 and p38 MAP kinase in doxorubicin-induced uPA expression in human RC-K8 lymphoma and NCI-H69 small cell lung carcinoma cells.
    Niiya M; Niiya K; Shibakura M; Asaumi N; Yoshida C; Shinagawa K; Teshima T; Ishimaru F; Ikeda K; Tanimoto M
    Oncology; 2004; 67(3-4):310-9. PubMed ID: 15557793
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Importance of the MKK6/p38 pathway for interleukin-12-induced STAT4 serine phosphorylation and transcriptional activity.
    Visconti R; Gadina M; Chiariello M; Chen EH; Stancato LF; Gutkind JS; O'Shea JJ
    Blood; 2000 Sep; 96(5):1844-52. PubMed ID: 10961885
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Scaffold role of a mitogen-activated protein kinase phosphatase, SKRP1, for the JNK signaling pathway.
    Zama T; Aoki R; Kamimoto T; Inoue K; Ikeda Y; Hagiwara M
    J Biol Chem; 2002 Jun; 277(26):23919-26. PubMed ID: 11959862
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role of TGF-beta1 and JNK signaling in capillary tube patterning.
    Bein K; Odell-Fiddler ET; Drinane M
    Am J Physiol Cell Physiol; 2004 Oct; 287(4):C1012-22. PubMed ID: 15201140
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Requirement of TGF-beta receptor-dependent activation of c-Jun N-terminal kinases (JNKs)/stress-activated protein kinases (Sapks) for TGF-beta up-regulation of the urokinase-type plasminogen activator receptor.
    Yue J; Sun B; Liu G; Mulder KM
    J Cell Physiol; 2004 May; 199(2):284-92. PubMed ID: 15040011
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Up-regulation of urokinase-type plasminogen activator by insulin-like growth factor-I depends upon phosphatidylinositol-3 kinase and mitogen-activated protein kinase kinase.
    Dunn SE; Torres JV; Oh JS; Cykert DM; Barrett JC
    Cancer Res; 2001 Feb; 61(4):1367-74. PubMed ID: 11245436
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Urokinase-type plasminogen activator potentiates lipopolysaccharide-induced neutrophil activation.
    Abraham E; Gyetko MR; Kuhn K; Arcaroli J; Strassheim D; Park JS; Shetty S; Idell S
    J Immunol; 2003 Jun; 170(11):5644-51. PubMed ID: 12759445
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Urokinase-type plasminogen activator gene regulation by polyomavirus middle-T antigen.
    Besser D; Urich M; Sakaue M; Messerschmitt A; Ballmer-Hofer K; Nagamine Y
    Oncogene; 1995 Dec; 11(11):2383-91. PubMed ID: 8570190
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The monofunctional alkylating agent N-methyl-N'-nitro-N-nitrosoguanidine triggers apoptosis through p53-dependent and -independent pathways.
    Kim WJ; Beardsley DI; Adamson AW; Brown KD
    Toxicol Appl Pharmacol; 2005 Jan; 202(1):84-98. PubMed ID: 15589979
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ceramide-enhanced urokinase-type plasminogen activator (uPA) release is mediated by protein kinase C in cultured microglia.
    Nakajima K; Honda S; Tohyama Y; Kurihara T; Kohsaka S
    Glia; 2000 Dec; 32(3):226-33. PubMed ID: 11102964
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of JNK, p38, and ERK in platelet-derived growth factor-induced vascular proliferation, migration, and gene expression.
    Zhan Y; Kim S; Izumi Y; Izumiya Y; Nakao T; Miyazaki H; Iwao H
    Arterioscler Thromb Vasc Biol; 2003 May; 23(5):795-801. PubMed ID: 12637337
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vomitoxin-induced cyclooxygenase-2 gene expression in macrophages mediated by activation of ERK and p38 but not JNK mitogen-activated protein kinases.
    Moon Y; Pestka JJ
    Toxicol Sci; 2002 Oct; 69(2):373-82. PubMed ID: 12377986
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of mitogen-activated protein kinases and c-Jun/AP-1 trans-activating activity in the regulation of protease mRNAs and the malignant phenotype in NIH 3T3 fibroblasts.
    Janulis M; Silberman S; Ambegaokar A; Gutkind JS; Schultz RM
    J Biol Chem; 1999 Jan; 274(2):801-13. PubMed ID: 9873019
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Regulation by p38 mitogen-activated protein kinase of adenylate- and uridylate-rich element-mediated urokinase-type plasminogen activator (uPA) messenger RNA stability and uPA-dependent in vitro cell invasion.
    Montero L; Nagamine Y
    Cancer Res; 1999 Oct; 59(20):5286-93. PubMed ID: 10537311
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Upregulation of urokinase-type plasminogen activator and inhibitor and gelatinase expression via 3 mitogen-activated protein kinases and PI3K pathways during the early development of osteoarthritis.
    Hsieh YS; Yang SF; Lue KH; Chu SC; Li TJ; Lu KH
    J Rheumatol; 2007 Apr; 34(4):785-93. PubMed ID: 17299841
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Induction of plasminogen activator by N-methyl-N'-nitro-N-nitrosoguanidine in mer+ and mer- human tumour cell strains.
    Brdar B; Matulić M
    Carcinogenesis; 1988 Dec; 9(12):2191-5. PubMed ID: 3191563
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Low concentration N-methyl-N'-nitro-N-nitrosoguanidine activates DNA polymerase-beta expression via cyclic-AMP-protein kinase A-cAMP response element binding protein pathway.
    Wang G; Yu Y; Chen X; Xie H
    Mutat Res; 2001 Jul; 478(1-2):177-84. PubMed ID: 11406182
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.